ATC代码 (A03)
外观
ATC代码 |
---|
A 消化系统和代谢系统 |
A01 口腔病药物 (Stomatological preparations) |
A02 治疗与胃酸分泌相关疾病的药物 (Drugs for acid related disorders) |
A03 肠胃机能失调用药 (Drugs for functional gastrointestinal disorders) |
A04 止吐药及止恶心药 (Antiemetics and antinauseants) |
A05 肝、胆疾病治疗药 (Bile and liver therapy) |
A06 轻泻药 (Laxatives) |
A07 止泻药、肠道消炎药、肠道抗感染药 (Antidiarrheals, intestinal anti-inflammatory /anti-infective agents) |
A08 减肥制剂,不包含饮食制品 (Antiobesity preparations, excluding diet products) |
A09 消化药,包括酶 (Digestives, including enzymes) |
A10 糖尿病用药 (Drugs used in diabetes) |
A11 维生素 (Vitamins) |
A12 矿物补充剂 (Mineral supplements) |
A13 补药 (Tonic) |
A14 同化作用药 (Anabolic agents for systemic use) |
A15 食欲促进剂 (Appetite stimulants) |
A16 其它消化道及新陈代谢用药 (Other alimentary tract and metabolism products) |
|
ATC代码A03(治疗功能性胃肠疾病的药物)是解剖学治疗学及化学分类系统的一个药物分组,这是由世界卫生组织药物统计方法整合中心(The WHO Collaborating Centre for Drug Statistics Methodology)所制定的药品及其它医用产品的官方分类系统。分组A03是A消化系统和代谢系统的一部分。[1]
兽用代码(ATCvet码)可以在人用ATC代码前加Q字母:QA03等[2]。没有相应人用ATC代码的ATCvet在以下列表中通过前置Q字母表示。
国家ATC分类可能包括列表中没有的其它分类,列表为世界卫生组织(WHO)版本。
A03A 治疗功能性肠道疾病的药物(Drugs for functional bowel disorders)
[编辑]A03AA 合成的抗胆碱能药物,带叔胺基团的酯类(Synthetic anticholinergics, esters with tertiary amino group)
[编辑]- A03AA01 羟苄利明(Oxyphencyclimine)
- A03AA03 卡米罗芬(Camylofin)
- A03AA04 美贝维林(Mebeverine)
- A03AA05 曲美布汀(Trimebutine)
- A03AA06 罗西维林(Rociverine)
- A03AA07 双环维林(Dicycloverine)
- A03AA08 双己维林(Dihexyverine)
- A03AA09 双苯美林(Difemerine)
- A03AA30 哌立度酯(Piperidolate)
A03AB 合成的抗胆碱能药物,季铵盐化合物类(Synthetic anticholinergics, quaternary ammonium compounds)
[编辑]- A03AB01 苯咯铵(Benzilone)
- A03AB02 格隆铵(Glycopyrronium)
- A03AB03 奥芬铵(Oxyphenonium)
- A03AB04 喷噻铵(Penthienate)
- A03AB05 丙胺太林(Propantheline)
- A03AB06 奥替溴铵(Otilonium bromide)
- A03AB07 甲胺太林(Methantheline)
- A03AB08 曲地铵(Tridihexethyl)
- A03AB09 异丙铵(Isopropamide)
- A03AB10 己环铵(Hexocyclium)
- A03AB11 泊尔定(Poldine)
- A03AB12 美喷酯(Mepenzolate)
- A03AB13 贝弗宁(Bevonium)
- A03AB14 哌喷酯(Pipenzolate)
- A03AB15 二苯马尼(Diphemanil)
- A03AB16 (2-二苯甲氧乙基)二乙基甲基碘铵((2-benzhydryloxyethyl)diethyl-methylammonium iodide)
- A03AB17 替莫碘胺(Tiemonium iodide)
- A03AB18 吡芬溴铵(Prifinium bromide)
- A03AB19 噻哌溴铵(Timepidium bromide)
- A03AB21 苯维铵(Fenpiverinium)
- A03AB53 奥芬溴铵,复方(Oxyphenonium, combinations)
- QA03AB90 苄替米特(Benzetimide)
- QA03AB92 碳酰胆碱(Carbachol)
- QA03AB93 新斯的明(Neostigmin)
A03AC 合成的解痉药,带叔胺的酰胺类(Synthetic antispasmodics, amides with tertiary amines)
[编辑]- A03AC02 二甲氨基丙基吩噻嗪(Dimethylaminopropionylphenothiazine)
- A03AC04 尼非他胺(Nicofetamide)
- A03AC05 苯酰胺桂胺(Tiropramide)
A03AE 作用于5-羟色胺受体的药物(Drugs acting on serotonin receptors)
[编辑]- A03AE01 阿洛司琼(Alosetron)
- A03AE02 替加色罗(Tegaserod)
- A03AE03 西兰司琼(Cilansetron)
- A03AE04 普卡必利(Prucalopride)
A03AX 治疗功能性肠道疾病的其它药物(Other drugs for functional bowel disorders)
[编辑]- A03AX01 芬哌丙烷(Fenpiprane)
- A03AX02 地索普明(Diisopromine)
- A03AX03 氯苄沙明(Chlorbenzoxamine)
- A03AX04 匹维铵(Pinaverium)
- A03AX05 非诺维林(Fenoverine)
- A03AX06 依丹帕明(Idanpramine)
- A03AX07 普罗沙唑(Proxazole)
- A03AX08 阿尔维林(Alverine)
- A03AX09 曲匹布通(Trepibutone)
- A03AX10 异美汀(Isometheptene)
- A03AX11 卡罗维林(Caroverine)
- A03AX12 间苯三酚(Phloroglucinol)
- A03AX13 硅氧烷(Silicones),包括西甲硅油(simeticone)
- A03AX30 三甲基二苯丙胺(Trimethyldiphenylpropylamine)
- A03AX58 阿尔维林复方(Alverine, combinations)
- QA03AX63 聚硅酮,复方Silicones, combinations
- QA03AX90 Physiostigmin
- QA03AX91 Macrogol ricinoleat (NFN)
A03B 颠茄及其衍生物(Belladonna and derivatives, plain)
[编辑]A03BA 颠茄生物碱,叔胺类(Belladonna alkaloids, tertiary amines)
[编辑]A03BB 半合成的颠茄生物碱,季铵盐类化合物(Belladonna alkaloids, semisynthetic, quaternary ammonium compounds)
[编辑]- A03BB01 丁基莨菪胺(Butylscopolamine)
- A03BB02 甲基阿托品(Methylatropine)
- A03BB03 甲基莨菪胺(Methylscopolamine)
- A03BB04 芬托铵(Fentonium)
- A03BB05 西托溴铵(Cimetropium bromide)
A03C 复方中有安定药的解痉药(Antispasmodics in combination with psycholeptics)
[编辑]A03CA 复方中有安定药的合成抗胆碱能药(Synthetic anticholinergic agents in combination with psycholeptics)
[编辑]- A03CA01 异丙铵和安定药(Isopropamide and psycholeptics)
- A03CA02 克利铵和安定药(Clidinium and psycholeptics)
- A03CA03 羟苄利明和安定药(Oxyphencyclimine and psycholeptics)
- A03CA04 奥替溴铵和安定药(Otilonium bromide and psycholeptics)
- A03CA05 格隆铵和安定药(Glycopyrronium and psycholeptics)
- A03CA06 贝弗宁和安定药(Bevonium and psycholeptics)
- A03CA07 安布溴铵和安定药(Ambutonium and psycholeptics)
- A03CA08 二苯马尼和安定药(Diphemanil and psycholeptics)
- A03CA30 依美铵和安定药(Emepronium and psycholeptics)
- A03CA34 丙胺太林和安定药(Propantheline and psycholeptics)
A03CB 复方中有安定药的颠茄及其衍生物(Belladonna and derivatives in combination with psycholeptics)
[编辑]- A03CB01 甲基莨菪胺和安定药(Methylscopolamine and psycholeptics)
- A03CB02 颠茄总生物碱和安定药(Belladonna total alkaloids and psycholeptics)
- A03CB03 阿托品和安定药(Atropine and psycholeptics)
- A03CB04 甲基后阿托品和安定药(Methylhomatropine and psycholeptics)
- A03CB31 莨菪碱和安定药(Hyoscyamine and psycholeptics)
A03CC 复方中有安定药的其它解痉药(Other antispasmodics in combination with psycholeptics)
[编辑]A03D 复方中有镇痛药的其它解痉药(Antispasmodics in combination with analgesics)
[编辑]A03DA 复方中有镇痛药的合成抗胆碱能药(Synthetic anticholinergic agents in combination with analgesics)
[编辑]- A03DA01 托齐林和镇痛药(Tropenzilone and analgesics)
- A03DA02 吡托非农和镇痛药(Pitofenone and analgesics)
- A03DA03 贝弗宁和镇痛药(Bevonium and analgesics)
- A03DA04 环隆铵和镇痛药(Ciclonium and analgesics)
- A03DA05 卡米罗芬和镇痛药(Camylofin and analgesics)
- A03DA06 曲司铵和镇痛药(Trospium and analgesics)
- A03DA07 替莫碘胺和镇痛药(Tiemonium iodide and analgesics)
A03DB 复方中有镇痛药的颠茄及其衍生物(Belladonna and derivatives in combination with analgesics)
[编辑]- A03DB04 丁基莨菪胺和镇痛药(Butylscopolamine and analgesics)
A03DC 复方中有镇痛药的其它解痉药(Other antispasmodics in combination with analgesics)
[编辑]A03E 复方中有其它药物的解痉药和抗胆碱能药(Antispasmodics and anticholinergics in combination with other drugs)
[编辑]A03EA 解痉药、安定药和镇痛药的复方(Antispasmodics, psycholeptics and analgesics in combination)
[编辑]A03ED 复方中有其它药物的解痉药(Antispasmodics in combination with other drugs)
[编辑]A03F 胃肠动力药(Propulsives)
[编辑]A03FA 胃肠动力药(Propulsives)
[编辑]- A03FA01 甲氧氯普胺(Metoclopramide)
- A03FA02 西沙必利(Cisapride)
- A03FA03 多潘立酮(吗叮啉)(Domperidone)
- A03FA04 溴必利(Bromopride)
- A03FA05 阿立必利(Alizapride)
- A03FA06 氯波必利(Clebopride)
- QA03FA90 毒扁豆碱(Physiostigmine)
参考文献
[编辑]- ^ ATC Index. WHO Collaborating Centre for Drug Statistics Methodology.
- ^ ATCvet Index. WHO Collaborating Centre for Drug Statistics Methodology.